Loading clinical trials...

COMPLETEDPhase 3NCT00603733

Canadian Active & Maintenance Modified Pentasa Study

The purpose of this study is to demonstrate that the new modified oral extended-release Pentasa® 500mg tablet is at least as efficacious as the currently marketed Pentasa® 500mg tablet in active mild ...

Lead sponsor: Ferring Pharmaceuticals•27 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 1/2

Superdonor FMT in Patients With Ulcerative Colitis

NCT05739864 · Active Ulcerative Colitis

RECRUITINGPhase 2

A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

NCT07232576 · Adult Patients With Moderately to Severely Active Ulcerative Colitis

RECRUITINGPhase 1

A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

NCT06681389 · Healthy Adult Volunteers, Active Ulcerative Colitis, and more

Active Not RecruitingPhase 3

A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06589986 · Moderately to Severely Active Ulcerative Colitis

COMPLETEDPhase 2

Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis

NCT03235752 · Active Ulcerative Colitis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 22, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment288

Start dateOct 2007

Last updatedApr 22, 2016

Condition

Active Ulcerative Colitis Remission of Ulcerative Colitis

Locations shown

University of Calgary, Faculty of Medicine

Calgary, Alberta

Castledowns Medicentre

Edmonton, Alberta

Investigational site

Brandon, Manitoba

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 22, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions